These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 16269171

  • 1. Effects of human papillomavirus type 16 E7 protein on the growth of cervical carcinoma cells and immuno-escape through the TGF-beta1 signaling pathway.
    Xu Q, Wang S, Xi L, Wu S, Chen G, Zhao Y, Wu Y, Ma D.
    Gynecol Oncol; 2006 Apr; 101(1):132-9. PubMed ID: 16269171
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.
    Diaz-Chavez J, Hernandez-Pando R, Lambert PF, Gariglio P.
    Mol Cancer; 2008 Jan 09; 7():3. PubMed ID: 18184435
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TGF-beta signalling pathway factors in HPV-induced cervical lesions.
    Iancu IV, Botezatu A, Goia-Ruşanu CD, Stănescu A, Huică I, Nistor E, Anton G, Pleşa A.
    Roum Arch Microbiol Immunol; 2010 Jan 09; 69(3):113-8. PubMed ID: 21434587
    [Abstract] [Full Text] [Related]

  • 7. miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway.
    Leung CO, Deng W, Ye TM, Ngan HY, Tsao SW, Cheung AN, Pang RT, Yeung WS.
    Carcinogenesis; 2014 Sep 09; 35(9):1931-40. PubMed ID: 24503442
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
    Tian Q, Huang J, Zhang Q, Zhao J.
    Clin Exp Pharmacol Physiol; 2024 Jun 09; 51(6):e13864. PubMed ID: 38679464
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F, Wang N, Wang S, Yu F, Sun X, Yu X, Luo B, Zhao C, Wang Y.
    Oncol Rep; 2017 Apr 09; 37(4):2324-2334. PubMed ID: 28260046
    [Abstract] [Full Text] [Related]

  • 14. Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry.
    El-Sherif AM, Seth R, Tighe PJ, Jenkins D.
    J Pathol; 2000 Dec 09; 192(4):494-501. PubMed ID: 11113867
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection.
    Baritaki S, Sifakis S, Huerta-Yepez S, Neonakis IK, Soufla G, Bonavida B, Spandidos DA.
    Int J Oncol; 2007 Jul 09; 31(1):69-79. PubMed ID: 17549406
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines.
    Ke LD, Adler-Storthz K, Mitchell MF, Clayman GL, Chen Z.
    Oral Oncol; 1999 Jul 09; 35(4):415-20. PubMed ID: 10645408
    [Abstract] [Full Text] [Related]

  • 18. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW, Chaturvedi PK, Chun SN, Lee YG, Ahn WS.
    Oncol Rep; 2015 Apr 09; 33(4):1675-82. PubMed ID: 25633640
    [Abstract] [Full Text] [Related]

  • 19. Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study.
    de Gruijl TD, Bontkes HJ, Walboomers JM, Stukart MJ, Doekhie FS, Remmink AJ, Helmerhorst TJ, Verheijen RH, Duggan-Keen MF, Stern PL, Meijer CJ, Scheper RJ.
    Cancer Res; 1998 Apr 15; 58(8):1700-6. PubMed ID: 9563486
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.